Literature DB >> 2194515

Hormonal changes in hemodialysis.

V Bonomini1, G Orsoni, M A Sorrentino, P Todeschini.   

Abstract

When chronic renal failure becomes advanced, the serum or tissue levels and/or the functions of most hormones are altered because of several interplaying mechanisms involving synthesis, transport, accumulation of inhibitors, abnormality of target organ responsiveness, and impaired renal clearance. As regular dialysis treatment is performed, most of these uremic hormone abnormalities are not reversed, and some of them may even get worse. The main endocrine derangements can be grouped as sexual hormone dysfunction, thyroid abnormalities, growth retardation, hormone-related disorders of metabolism, derangements of pressor substances, gastrointestinal peptide abnormalities, renal osteodystrophy, and anemia. The endocrine abnormalities play a major role as for the clinical and metabolic rehabilitation of dialysis patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194515     DOI: 10.1159/000169926

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Transient impact of hemodialysis on gastric myoelectrical activity of uremic patients.

Authors:  C W Ko; C S Chang; M J Wu; G H Chen
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

2.  Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment.

Authors:  G Napolitano; M Bonomini; G Bomba; I Bucci; V Todisco; A Albertazzi; F Monaco
Journal:  Biol Trace Elem Res       Date:  1996-12       Impact factor: 3.738

3.  Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.

Authors:  P Trelewicz; W Grzeszczak; R Drabczyk
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 4.  Isolated Adrenocorticotropic Hormone Deficiency and Primary Hypothyroidism in a Patient Undergoing Long-Term Hemodialysis: A Case Report and Literature Review.

Authors:  Nobumasa Ohara; Michi Kobayashi; Masafumi Tuchida; Ryo Koda; Yuichiro Yoneoka; Noriaki Iino
Journal:  Am J Case Rep       Date:  2020-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.